Navigation Links
deCODE Launches deCODEme(TM)
Date:11/16/2007

The company that has led in the discovery of genes that confer risk of common diseases is empowering individuals to explore their own genome

Webcast to be held at 9 AM EST

REYKJAVIK, Iceland, Nov. 16 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODEme(TM), a pioneering service that enables individuals to get a detailed look at their own genome.

Through your subscription to deCODEme(TM), you can learn what your DNA says about your ancestry, your body --traits such as hair and eye color-- as well as whether you may have genetic variants that have been associated with higher or lower than average risk of a range of common diseases. This information will be continually updated as new discoveries are made.

Subscribers will create a secure password-controlled personal account. Just a few weeks after sending in a simple cheek swab, customers will receive expert analysis of more than a million key variants across their genome, accessible through an easy-to-use and intuitive user interface.

With deCODEme(TM), your DNA is in the hands of a global leader in human genetics. In more than a decade of pioneering research, deCODE has analyzed the genomes of hundreds of thousands of people from around the world, developing an unrivalled track record in gene discovery, in systems for genetic analysis, as well as data and privacy protection. deCODEme(TM) puts this expertise to work for you. The introductory promotional price of a subscription to deCODEme is $985. Starting today, deCODEme(TM) is accepting subscription orders and we will be soliciting feedback from these first customers to optimize the service experience. To learn more about de
'/>"/>

SOURCE deCODE genetics
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
2. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
3. deCODE genetics Announces Third Quarter 2007 Financial Results
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. Novozymes Launches Enzyme to Reduce Acrylamide in Food
6. Enova Medical Launches Exos Corporation
7. Elekta Launches New Linear Accelerator at 2007 ESTRO to Expand Cancer Treatment Availability
8. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
9. ThirdBiotech Networking Group Launches
10. BioReliance Launches Next-Generation Genotoxicity Screening Service
11. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)..., Calif., Nov. 6 Intarcia Therapeu...s ITCA 650 (DUROS® continuous delivery of exe...es at the Ninth Annual Diabetes Technology Meeting...wscom.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,...Via ITCA 650 Lowers Plasma Glucose, HbA1c and Redu...
(Date:11/5/2009)...ANY, N.J., Nov. 5 DSM Pharmaceutic...ufacturing alliance with Galenix, Saint Jean D,Ill...cial scale manufacturing partner for Galenix comme...lenix will collaborate on business development opp...nologies, based on the strength of Galenix in drug...
(Date:11/5/2009)...K, N.Y., Nov. 5 BioSpeci...rmaceutical company developing first-in-class coll...ial results for the third quarter ended September ... September of this year, the FDA,s Arthritis Advis...f 12-0, the approval of XIAFLEX(TM) for the treatm...
(Date:11/5/2009)... Texas, Nov. 5 SpineSmith Partners...c. to co-develop a unique scaffold that mimics the...evaluation of several commercial products by Spine...ompany believes the GenOsteo scaffold represents a...s a unique and ideal environment for the delivery ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...zone and Nitrofurantoine belong to the group of ni...tment of gastrointestinal infections in cattle and...enic effect, nitrofuranes (except for furazolidone... (EWG) No. 2901/93). Furazolidone was prohibited i...o. 1441/95). They are mentioned in appendix IV of ...
... of Edman sequence analysis and electrospray tande... structural data of highlyknotted spider toxins ,...structure determination of disulfide bridged pepti...the Procise cLC 492 sequencing system and the QSTA...ctrometer. These two techniques provide complement...
...lt or generally not to analyse by GC/MS, , ...ter simple solvent extraction , and fast ...ched standards. , The drawback of MS/MS m... each target analyte. This effort can signi...ard parameters, which are given in the attached CD...
Other Biology Technology:Detection of nitrofurane metabolites in food with HPLC/MS/MS 2Efficient Primary Structure Elucidation of Disulfide-bridged Peptides 2Efficient Primary Structure Elucidation of Disulfide-bridged Peptides 3Efficient Primary Structure Elucidation of Disulfide-bridged Peptides 4Efficient Primary Structure Elucidation of Disulfide-bridged Peptides 5Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 2Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 3Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 4Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 5Simultaneous Determination of Residues of Approximately 100 Pesticides , and Metabolites in Fruit and Vegetables by LC/MS/MS 6
(Date:11/8/2009)...ON DESIGNED FOR ADULTS WITH INTELLECTUAL DISABILIT...diana University study involving adults with intel...ed their personal health knowledge after taking a ... ID, an internationally accepted term for mental r... physical inactivity and preventable chronic disea...
(Date:11/6/2009)...50th anniversary this month of the publication of ...f Biological Sciences (AIBS) is publishing open ac...in and his historic insights into evolution. , Th...ty of California, Berkeley, and James T. Costa of ...n Myths About Charles Darwin," appeared in the Oct...
(Date:11/6/2009)...6 Auburn Hills, MI-based Law Enfor...talling its locker system and patent-pending Biome...Department of Health and Human Services, National ... The locker system will support the NIH,s entire p... nation,s medical research agency. The project is...
Breaking Biology News(10 mins):Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3As Sleep Improves Grades Seem to Go Up 48427 1As Sleep Improves Grades Seem to Go Up 48427 2MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 1MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 2MDS Nordion Begins to Manufacture Cardiac Imaging Agent 48425 3MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip 48421 1MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip 48421 2MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip 48421 3
...mental threat has been detected in North American ...ities. , Along with scientists from several Canad...ed biological damage caused by declining levels of...alling the phenomenon "aquatic osteoporosis," Quee...he study, notes that calcium is an essential nutri...
...vernment of Cameroon, and other partners have coll...tect the world,s most endangered great ape: the Cr...n important trans-boundary protected area with Nig...estimated 115 gorillasa third of the Cross River g...ans-boundary protected areas allow species to roam...
...ited States has been under assault for decades by ... is not often that one of these aliens faces a cou...eral other institutions, the University of Rhode I... an insect pest that regularly disfigures birch tr...t. And the credit goes to entomologists from URI ...
Other Biology News:Queen's University biologists find new environmental threat in North American lakes 2New national park protects world's rarest gorilla 2New national park protects world's rarest gorilla 3URI researchers help score knockout punch on birch tree pest 2
pORF-eSEAP from InvivoGen
...s have triple baffles located at the center of the...o culture medium. These flasks have a large markin...le for these bottles including:, Polypropylene co..., Vented membrane cap with 0.22m PTFE hydrophobic ...
...NA samples., , This product has been optimised... have been pre-purified using traditional methods ...o dT etc or other kits. , Our StabMRT Kits conta...ion of nanogram to milligram quantities of RNA. ,...
SkanWasher 400 from Molecular Devices
Biology Products: